@article{eec8eb52de0944d8adf9610e5dca938d,
title = "Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy",
abstract = "The T-cell engager monoclonal antibody, blinatumomab, is a potential therapeutic strategy for refractory B acute lymphoblastic leukemia after failure of CD 19 chimeric antigen receptor T-cell therapy.",
keywords = "acute lymphoblastic leukemia, blinatumomab, chimeric antigen receptor",
author = "Tambaro, {Francesco Paolo} and Sajad Khazal and Cesar Nunez and Dristhi Ragoonanan and Priti Tewari and Demetrios Petropoulos and Partow Kebriaei and Wierda, {William George} and Mahadeo, {Kris Michael}",
note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",
year = "2020",
month = sep,
day = "1",
doi = "10.1002/ccr3.2918",
language = "English (US)",
volume = "8",
pages = "1678--1681",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
number = "9",
}